Helix BioMedix Reports Second Quarter 2010 Financial Results
BOTHELL, Wash.–(BUSINESS WIRE)–Helix BioMedix, Inc. (OTCBB: HXBM), a developer of bioactive peptides, today announced financial results for the company’s second quarter 2010 ended June 30, 2010. Second Quarter 2010 and Recent Highlights: Recorded record revenue of approximately $330,000 in the second quarter of 2010, compared to approximately $138,000 in the same period a year ago, an increase …

Read more on Business Wire

Reliv International Reports Second-Quarter 2010 Results
News), a nutrition and direct selling company, today reported consolidated net sales of $18.8 million for the second quarter of 2010, compared to net sales of $20.1 million in the second quarter of last year. Â International sales rose 18.7 percent compared to the same quarter in 2009, but U.S. sales were down 9.5 percent in the quarter.

Read more on PR Newswire via Yahoo! Finance